MA26912A1 - 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione iodhydrique en tant que produit pharmaceutique - Google Patents

5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione iodhydrique en tant que produit pharmaceutique

Info

Publication number
MA26912A1
MA26912A1 MA26936A MA26936A MA26912A1 MA 26912 A1 MA26912 A1 MA 26912A1 MA 26936 A MA26936 A MA 26936A MA 26936 A MA26936 A MA 26936A MA 26912 A1 MA26912 A1 MA 26912A1
Authority
MA
Morocco
Prior art keywords
iodhydric
pyridil
thiazolidine
dione
ethoxy
Prior art date
Application number
MA26936A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael John Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA26912A1 publication Critical patent/MA26912A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA26936A 2000-06-08 2002-12-05 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione iodhydrique en tant que produit pharmaceutique MA26912A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0014005.3A GB0014005D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
MA26912A1 true MA26912A1 (fr) 2004-12-20

Family

ID=9893256

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26936A MA26912A1 (fr) 2000-06-08 2002-12-05 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione iodhydrique en tant que produit pharmaceutique

Country Status (26)

Country Link
US (1) US20040024027A1 (fr)
EP (1) EP1292595A1 (fr)
JP (1) JP2003535861A (fr)
KR (1) KR20030007919A (fr)
CN (1) CN1443185A (fr)
AP (1) AP2002002684A0 (fr)
AU (2) AU2001262550B2 (fr)
BG (1) BG107356A (fr)
BR (1) BR0111508A (fr)
CA (1) CA2411064A1 (fr)
CZ (1) CZ20024029A3 (fr)
DZ (1) DZ3383A1 (fr)
EA (1) EA004298B1 (fr)
GB (1) GB0014005D0 (fr)
HU (1) HUP0301799A3 (fr)
IL (1) IL153280A0 (fr)
MA (1) MA26912A1 (fr)
MX (1) MXPA02012173A (fr)
NO (1) NO20025882L (fr)
NZ (1) NZ522997A (fr)
OA (1) OA12283A (fr)
PL (1) PL363683A1 (fr)
SK (1) SK17152002A3 (fr)
WO (1) WO2001094343A1 (fr)
YU (1) YU93002A (fr)
ZA (1) ZA200300017B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (fr) * 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EA004298B1 (ru) 2004-02-26
BG107356A (bg) 2003-06-30
SK17152002A3 (sk) 2003-05-02
JP2003535861A (ja) 2003-12-02
PL363683A1 (en) 2004-11-29
IL153280A0 (en) 2003-07-06
HUP0301799A2 (hu) 2003-12-29
GB0014005D0 (en) 2000-08-02
AP2002002684A0 (en) 2002-12-31
OA12283A (en) 2003-11-10
AU6255001A (en) 2001-12-17
NO20025882D0 (no) 2002-12-06
BR0111508A (pt) 2003-03-25
EP1292595A1 (fr) 2003-03-19
AU2001262550B2 (en) 2004-04-22
ZA200300017B (en) 2004-04-08
CA2411064A1 (fr) 2001-12-13
DZ3383A1 (fr) 2001-12-13
EA200300004A1 (ru) 2003-04-24
HUP0301799A3 (en) 2005-04-28
MXPA02012173A (es) 2003-04-25
YU93002A (sh) 2006-01-16
NO20025882L (no) 2003-01-29
KR20030007919A (ko) 2003-01-23
CN1443185A (zh) 2003-09-17
US20040024027A1 (en) 2004-02-05
WO2001094343A1 (fr) 2001-12-13
CZ20024029A3 (cs) 2003-04-16
NZ522997A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
ATE302202T1 (de) Hcl-salze von 5-(4-(2-(n-methyl-n-(2- pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dio
DE60004196D1 (de) Polymorph von 5-[4-[2-(n-methyl-n-(2-pyrdyl)amino)äthoxy]benzyl]thiazolidin-2,4-dion, maleinsäuresalz
NO20003069D0 (no) 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]tiazolidin- 2,4-dion-maleinsyre-salt-hydrat som farmasøytikum
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
DZ3383A1 (fr) 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione iodhydrique en tant que produit pharmaceutique
AU2002343036A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
MA25908A1 (fr) Chlorhydrate de 5-(4(2-(n-methyl-n-(2-pyridyl) amino) ethoxy) benzyl)thiazolidine-2,4-dione.
CY1107252T1 (el) Τρυγικο αλας παραγωγου της θειζολιδινοδιονης
DK1349855T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
MA25912A1 (fr) Sels de sodium de 5- (4-(2-(n-methyl-n-(2-pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione
SI1265893T1 (sl) Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona